Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | -8.47%602.93M | ---- | 15.61%658.75M | ---- | 101.01%569.79M | ---- | 207.02%283.47M | ---- | -126.01%-264.87M | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | 20.83%-31.59M | ---- | 50.74%-39.9M | ---- | -110.25%-81.01M | ---- | -131.90%-38.53M | ---- | 61.50%-16.62M | ---- |
| Attributable subsidiary (profit) loss | -11.29%25.59M | ---- | -72.13%28.85M | ---- | 441.57%103.51M | ---- | 44.63%-30.3M | ---- | -194.15%-54.72M | ---- |
| Impairment and provisions: | 207.70%184.33M | ---- | 20.73%59.91M | ---- | -58.23%49.62M | ---- | -86.32%118.78M | ---- | --868.51M | ---- |
| -Impairment of property, plant and equipment (reversal) | 102.22%7.29M | ---- | -89.24%3.61M | ---- | -63.63%33.53M | ---- | -29.46%92.21M | ---- | --130.72M | ---- |
| -Impairment of goodwill | ---- | ---- | ---- | ---- | ---- | ---- | --42.09M | ---- | ---- | ---- |
| -Other impairments and provisions | 214.46%177.03M | ---- | 250.02%56.3M | ---- | 203.61%16.08M | ---- | -102.10%-15.52M | ---- | --737.79M | ---- |
| Revaluation surplus: | 57.46%-11.44M | ---- | -175.43%-26.88M | ---- | 586.75%35.64M | ---- | 81.58%-7.32M | ---- | -482.49%-39.76M | ---- |
| -Other fair value changes | 57.46%-11.44M | ---- | -175.43%-26.88M | ---- | 586.75%35.64M | ---- | 81.58%-7.32M | ---- | -168.18%-39.76M | ---- |
| Asset sale loss (gain): | 236.89%4.93M | ---- | -84.11%1.46M | ---- | -27.19%9.21M | ---- | -52.45%12.65M | ---- | -49.54%26.61M | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | -102.29%-682K | ---- | -52.38%29.79M | ---- |
| -Loss (gain) on sale of property, machinery and equipment | 236.89%4.93M | ---- | -87.30%1.46M | ---- | -13.56%11.53M | ---- | --13.34M | ---- | ---- | ---- |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---2.31M | ---- | ---- | ---- | 85.57%-3.18M | ---- |
| Depreciation and amortization: | -0.83%1.85B | ---- | 9.07%1.87B | ---- | 8.32%1.71B | ---- | -6.44%1.58B | ---- | 42.89%1.69B | ---- |
| -Amortization of intangible assets | -0.85%222.14M | ---- | 37.31%224.04M | ---- | 26.58%163.16M | ---- | -31.62%128.91M | ---- | 68.86%188.52M | ---- |
| Financial expense | -15.85%965.44M | ---- | -16.37%1.15B | ---- | -23.93%1.37B | ---- | 18.74%1.8B | ---- | 14.73%1.52B | ---- |
| Special items | 99.93%-18K | ---- | 92.78%-24.74M | ---- | -346.05%-342.57M | ---- | -1,115.59%-76.8M | ---- | 60.60%-6.32M | ---- |
| Operating profit before the change of operating capital | -2.18%3.59B | ---- | 7.12%3.67B | ---- | -5.98%3.43B | ---- | -2.01%3.64B | ---- | 6.53%3.72B | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | -45.82%10.99M | ---- | 6.85%20.27M | ---- | 289.05%18.98M | ---- | -121.08%-10.04M | ---- | -44.87%47.61M | ---- |
| Accounts receivable (increase)decrease | 161.06%522.77M | ---- | -678.65%-856.09M | ---- | -84.25%147.95M | ---- | 170.23%939.53M | ---- | 46.08%-1.34B | ---- |
| Accounts payable increase (decrease) | 90.85%-67.7M | ---- | 53.21%-740.02M | ---- | -71.34%-1.58B | ---- | 80.36%-923.15M | ---- | -161.96%-4.7B | ---- |
| prepayments (increase)decrease | -167.52%-189.86M | ---- | 305.58%281.19M | ---- | 60.03%-136.78M | ---- | -113.30%-342.2M | ---- | 696.60%2.57B | ---- |
| Special items for working capital changes | -311.82%-66.24M | ---- | -80.52%31.27M | ---- | -73.43%160.53M | ---- | -73.03%604.12M | ---- | -23.98%2.24B | ---- |
| Cash from business operations | 57.87%3.8B | ---- | 18.25%2.41B | ---- | -47.97%2.04B | ---- | 53.91%3.91B | ---- | 39.82%2.54B | ---- |
| China income tax paid | 20.20%-200.39M | ---- | -9.38%-251.11M | ---- | 7.54%-229.57M | ---- | 0.04%-248.29M | ---- | -22.87%-248.39M | ---- |
| Other taxs | 1.68%-49.26M | ---- | 23.45%-50.1M | ---- | -116.47%-65.45M | ---- | -70.47%397.43M | ---- | 139.02%1.35B | ---- |
| Special items of business | -1.68%49.26M | 3.74%633M | -23.45%50.1M | -19.63%610.2M | 116.47%65.45M | -46.82%759.21M | 70.47%-397.43M | 120.50%1.43B | -139.02%-1.35B | -41.86%647.46M |
| Net cash from operations | 66.97%3.6B | 3.74%633M | 19.38%2.16B | -19.63%610.2M | -50.71%1.81B | -46.82%759.21M | 59.75%3.66B | 120.50%1.43B | 41.94%2.29B | -41.86%647.46M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -20.83%31.59M | -36.04%19.18M | -50.74%39.9M | 46.84%29.98M | 110.25%81.01M | 193.15%20.42M | 131.90%38.53M | 69.92%6.97M | -61.50%16.62M | -68.88%4.1M |
| Dividend received - investment | 171.32%4.26M | ---- | -60.63%1.57M | ---- | --3.99M | ---- | ---- | ---- | ---- | ---- |
| Restricted cash (increase) decrease | -101.10%-1.2M | -77.13%14.12M | 1,910.15%109.12M | 273.98%61.74M | 85.14%-6.03M | -6.00%-35.49M | -123.10%-40.56M | -116.70%-33.48M | 473.75%175.6M | 335.08%200.43M |
| Loan receivable (increase) decrease | 461.89%165.6M | ---- | -27.38%29.47M | ---- | -74.26%40.58M | ---- | -57.81%157.68M | ---- | -49.10%373.72M | ---- |
| Sale of fixed assets | ---- | ---- | -97.09%117K | --1.17M | -57.56%4.02M | ---- | 68.17%9.46M | --1.42M | -55.86%5.63M | ---- |
| Purchase of fixed assets | -29.47%-1.61B | -10.75%-475.63M | 14.16%-1.24B | 56.81%-429.48M | -49.68%-1.45B | -185.99%-994.35M | 28.24%-966.38M | 44.78%-347.69M | 36.60%-1.35B | 60.14%-629.6M |
| Purchase of intangible assets | 13.99%-6.57M | 27.50%-1.85M | 78.76%-7.64M | 68.97%-2.56M | -175.39%-35.98M | -43,257.89%-8.24M | 159.68%47.72M | 99.86%-19K | 67.72%-79.96M | 41.16%-13.25M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | 500.81%25.71M | 136.92%2.46M | -135.07%-6.41M | ---6.65M | -97.06%18.29M | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | 3.03%-243.98M | ---261.69M | -95.06%-251.61M | ---- | 82.06%-128.99M | -188.35%-3.97M |
| Recovery of cash from investments | -5.54%127.52M | ---- | 163.52%135.01M | --136.93M | -88.92%51.23M | ---- | 67.92%462.31M | --356.9M | --275.32M | ---- |
| Cash on investment | -20.62%-267.7M | -24,823.08%-162M | 63.36%-221.93M | 99.87%-650K | -22.21%-605.75M | -1,139.88%-492.02M | 50.21%-495.66M | -173.52%-39.68M | 14.73%-995.56M | 103.12%53.98M |
| Other items in the investment business | 11.19%-51.42M | 107.68%40.82M | 70.18%-57.89M | -577.29%-531.28M | 42.51%-194.15M | 111.48%111.31M | 59.72%-337.74M | 18.56%-969.78M | -1,946.06%-838.57M | -238.67%-1.19B |
| Net cash from investment operations | -32.26%-1.61B | 22.99%-565.37M | 47.81%-1.21B | 55.71%-734.15M | -68.21%-2.33B | -60.62%-1.66B | 45.23%-1.38B | 34.64%-1.03B | 11.36%-2.52B | 10.43%-1.58B |
| Net cash before financing | 111.67%1.99B | 154.56%67.62M | 281.38%942.43M | 86.20%-123.95M | -122.77%-519.6M | -327.06%-898.39M | 1,089.45%2.28B | 142.47%395.66M | 81.28%-230.63M | -43.50%-931.58M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -7.08%7.43B | -13.45%4.88B | -5.66%7.99B | 20.88%5.63B | -38.25%8.47B | -33.21%4.66B | 53.90%13.72B | 50.35%6.98B | 48.22%8.92B | 324.99%4.64B |
| Refund | 14.80%-9.2B | 47.98%-3.52B | -17.08%-10.79B | -110.15%-6.77B | 29.52%-9.22B | 58.57%-3.22B | -64.34%-13.08B | -176.54%-7.77B | -31.19%-7.96B | -820.00%-2.81B |
| Issuing shares | ---- | ---- | ---- | ---- | ---- | ---- | --4.69B | --4.68B | ---- | ---- |
| Issuance of bonds | 404.31%1.82B | -35.09%-92.84M | 371.98%361.49M | ---68.72M | 77.35%-132.91M | ---- | -5.91%-586.9M | ---- | -154.99%-554.15M | ---- |
| Interest paid - financing | 16.06%-968.73M | 16.04%-559.84M | 16.47%-1.15B | 15.85%-666.81M | 13.36%-1.38B | -12.86%-792.43M | -19.27%-1.59B | 4.73%-702.16M | -0.01%-1.34B | 1.51%-737.05M |
| Dividends paid - financing | -551.58%-322.48M | -1,482.28%-301.03M | ---49.49M | ---19.03M | ---- | ---- | ---- | ---- | ---- | ---- |
| Absorb investment income | -97.49%50.35M | ---- | -49.95%2B | --2B | --4B | ---- | ---- | ---- | 358.29%7.74M | --600K |
| Issuance expenses and redemption of securities expenses | ---- | ---- | ---- | ---- | ---- | 92.76%-78.71M | ---- | ---1.09B | ---1.22B | ---- |
| Other items of the financing business | 248.10%160.96M | 110.40%9.32M | -1,045.83%-108.69M | -1,147.04%-89.57M | 100.41%11.49M | -77.07%8.56M | -399.63%-2.8B | -98.07%37.3M | 365.19%933.24M | 41.59%1.93B |
| Net cash from financing operations | 41.40%-1.02B | 1,765.19%410.4M | -199.82%-1.75B | -96.19%22M | 401.02%1.75B | -72.91%577.15M | 128.83%349.56M | 180.24%2.13B | -555.21%-1.21B | 506.14%760.19M |
| Effect of rate | -86.75%224K | 76.20%-782K | -61.24%1.69M | 97.61%-3.29M | 103.23%4.36M | -546.31%-137.76M | -316.65%-135.05M | -189.21%-21.32M | -74.01%62.33M | 139.45%23.89M |
| Net Cash | 220.44%970.45M | 568.91%478.02M | -165.41%-805.72M | 68.27%-101.94M | -53.19%1.23B | -112.72%-321.24M | 282.36%2.63B | 1,573.85%2.53B | -1.83%-1.44B | 79.51%-171.39M |
| Begining period cash | -18.07%3.65B | -18.07%3.65B | 38.47%4.45B | 22.34%4.45B | 181.68%3.21B | 218.83%3.64B | -54.76%1.14B | -54.76%1.14B | -31.83%2.52B | -31.83%2.52B |
| Cash at the end | 26.63%4.62B | -5.10%4.12B | -18.07%3.65B | 36.69%4.34B | 22.34%4.45B | -12.82%3.18B | 218.83%3.64B | 53.56%3.65B | -54.76%1.14B | -15.27%2.37B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.